A cyclical exchange of citrate has been shown to exist in the intact organism, with the blood plasma serving as the transporting medium. In vivo studies have indicated a considerable uptake of citrate by the liver (1) and kidney (2), and a release of citrate into the blood by the peripheral tissues (1, 3) and intestine (4,5). Interest in the blood citrate flux has centered primarily around the importance of this intermediate in carbohydrate metabolism, in its relationship to calcium mobilization and deposition in bone (6), and in its role as a chelating agent for calcium in the urine (7, 8).The studies reported here have been concerned with an attempt to elucidate the metabolic fate of the blood citrate in rats with the aid of radioactive citrate. The data, obtained by following the pattern of respiratory C140, and the urinary excretion of radioactive carbon after the intravenous administration of sodium citrate-1,5-C'4, indicated a rapid turnover of the blood citrate. Three hours after injection of the labeled citrate, approximately 90 per cent of the radioactivity was recovered in the respiratory CO., and in the urinary citrate. Evidence for the utilization of blood citrate as a precursor of tissue components was provided by assaying the C14 content of protein and lipid of kidneys and liver after intravenous citrate-C14 administration.In an effort to define further the metabolic fate of the blood citrate, inhibitors of citrate oxidation were administered prior to citrate-C14 administration. Peters (9) Fed, female Sprague-Dawley rats, weighing between 185 and 235 g, were used. Citric acid-1,5-C"' was obtained from Tracerlab, Inc., and sodium acetate--C1'4 from Volk Radiochemical Co. Sodium fluoroacetate 1 was purchased from Bios Laboratories, Inc. Barium fluorocitrate, synthesized by the method of Rivett (10), was obtained from the Sonbert Chemical Co., Brooklyn, N. Y.; this preparation contained less than 1 per cent barium citrate by specific analysis. Before use, the barium salt was dissolved in dilute HCl, the barium was precipitated with saturated sodium sulfate and the supernatant fluid was neutralized with dilute NaOH. Solutions of the fluoroinhibitors were freshly prepared prior to use.In the in vivo experiments, sodium citrate-1,5-C"4 in isotonic saline was given intravenously in a volume of 0.3 ml. Collection of respiratory CO2 was accomplished by drawing CO2-free air through a glass metabolism jar containing the rat, and the respiratory CO2 was trapped in NaOH. Barium carbonate precipitates were prepared from aliquots of the NaOH solutions. After the BaCO3 was washed with water and then alcohol, it was plated and counted in a Nuclear-Chicago gas-flow counter with a Micromil window. Urine collections were made up to standard volume, and aliquots were taken for direct plating and for conversion of the carboxyl groups of the urinary citrate to CO2 with ceric sulfate (11); the CO2